Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

$443.6 Bn Microtome Global Market Trends, Opportunities and Strategies, 2019-2024, 2025-2029F, 2034F: Top 10 Players Hold 26.56% Share Led by Danaher, Thermo Fisher Scientific, and Sakura Finetek

globenewswire.com
DHR Danaher is mentioned as a leading player in the microtome market, holding a 4.49% share. The article provides market growth forecasts and trends, but no specific positive or negative outlook for Danaher itself. TMO Thermo Fisher Scientific is identified as a leading player in the microtome market with a 3.31% share. The article discusses overall market growth and opportunities, but does not offer specific sentiment towards Thermo Fisher. CAH Cardinal Health is listed as a significant player in the microtome market. The article focuses on market trends and growth, without providing specific sentiment for Cardinal Health.

Dublin, Jan. 08, 2026 (GLOBE NEWSWIRE) -- The "Microtome Global Market Opportunities and Strategies to 2034" has been added to ResearchAndMarkets.com's offering.

The microtome market report forecasts significant growth, evaluating the market by regions, major economies, products, technology, applications, and end-users. The global microtome market was valued at approximately $244.63 million in 2024, with a compound annual growth rate (CAGR) of 4.24% since 2019. This is anticipated to grow to $335.05 million by 2029, at a CAGR of 6.49%, and reach $443.58 million by 2034 with a rate of 5.77%.

Key growth drivers include the rising focus on personalized medicine, increasing clinical trials, and advancements in 3D tissue and organoid research. Challenges faced during the historical period include the high costs of advanced equipment and a scarcity of skilled technicians. Future growth will be fueled by increased applications in drug discovery, toxicology studies, expanding research facilities, and advancements in regenerative medicine and stem cell research. However, hurdles such as mechanical complexity, calibration demands, and geopolitical trade issues might impact the market.

In 2024, North America dominated the microtome market with a 35.61% share or $87.1 million, followed by Asia-Pacific, Western Europe, and other regions. The fastest-growing regions are expected to be Asia-Pacific and Western Europe, with CAGRs of 7.12% and 7.03%, respectively. The Middle East and North America are projected to have CAGRs of 6.42% and 6.24% respectively.

The market remains fairly concentrated, with the top 10 competitors holding 26.56% of the market in 2024. Leading players include Danaher Corporation (4.49%), Thermo Fisher Scientific Inc. (3.31%), and Sakura Finetek Inc. (3.07%). Other significant players are Cardinal Health Inc., BIOBASE Group, and AGD Biomedicals Pty Ltd.

The microtome market is segmented by product into instruments and accessories. Instruments comprise the largest segment, representing 67.50% or $165.13 million in 2024. However, the accessories segment is expected to grow fastest, with a forecasted CAGR of 10.40% for 2024-2029.

By technology, the market is segmented into fully automated, semi-automated, and manual microtomes. Fully automated microtomes led the market in 2024, accounting for 54.36% or $132.98 million. This segment is projected to maintain the fastest growth with a CAGR of 7.09% from 2024-2029.

Applications of microtomes are divided into disease diagnosis and medical research, with disease diagnosis leading at 65.19% or $159.47 million in 2024. It will continue to be the fastest-growing application, projected at a CAGR of 7.57% for 2024-2029.

The market's end-user segments include hospitals, clinical and diagnostic laboratories, academic research centers, and others. Hospitals held the largest share at 36.55% or $89.42 million in 2024. The clinical and diagnostic laboratories segment is expected to grow at a CAGR of 7.90% during 2024-2029.

The report highlights opportunities for growth, especially in the instruments segment, expected to gain $39.54 million. The fully automated technology segment will see a $54.3 million increase, while the disease diagnosis application is set to rise by $70.16 million. Among end-users, the hospitals segment will gain $31.07 million by 2029, with the USA predicting a $27.47 million increase.

Strategic recommendations include emphasizing technical center expansions for innovation, focusing on the development of next-generation microtomes, and improving automation technologies for precision. Companies are advised to target growth in the accessories segment, emerging markets, and developed markets, alongside focusing on competitive pricing and B2B promotions.

Key Attributes:

Report Chapters Include:

Companies Featured

For more information about this report visit https://www.researchandmarkets.com/r/knhtn1

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment